Idenix Pharmaceuticals To Present At The Wells Fargo Securities 2013 Healthcare Conference

CAMBRIDGE, Mass., June 11, 2013 (GLOBE NEWSWIRE) -- Idenix Pharmaceuticals, Inc. (Nasdaq:IDIX) announced today that Idenix management will present a corporate overview at the Wells Fargo Securities 2013 Healthcare Conference on Tuesday, June 18, 2013, at 1:10 p.m. ET at the InterContinental Hotel in Boston, MA. Management will also participate in a panel discussion on Hepatitis C earlier in the day at 10:00 a.m. ET.  

The live and archived webcast of the Company presentation can be accessed under "Events and Presentations" in the Idenix Investor Center at www.idenix.com . The archived replay will be available on the Idenix website for two weeks following the conference.

ABOUT IDENIX PHARMACEUTICALS

Idenix Pharmaceuticals, Inc., headquartered in Cambridge, Massachusetts, is a biopharmaceutical Company engaged in the discovery and development of drugs for the treatment of human viral diseases.  Idenix's current focus is on the treatment of patients with hepatitis C virus (HCV) infection. For further information about Idenix, please refer to www.idenix.com .
CONTACT: Teri Dahlman         (617) 995-9807

Idenix Pharmaceuticals logo

If you liked this article you might like

Buffett and Billionaire Investors Look to Oil, Health Care and Spinoffs in 2015

Health Care Stocks: A Year in Review and Predictions for 2015

'Fast Money' Recap: Next Stop, S&P 2,100?

Cramer: Every Which Way But Short

Sarissa Capital: Good Start With Idenix Pharmaceuticals Buyout